Following up what Kay Diederichs recently wrote, each page of Proteopedia that 
contains user added comments have a visible banner on the top,
e.g. see: https://proteopedia.org/w/2bs2
n.b. these user added comments are all signed, i.e. they are NOT anonymous, so 
it is a good location to consider user discussion on structural studies.

Joel


On 22Jul, 2019, at 14:16, Kay Diederichs 
<kay.diederi...@uni-konstanz.de<mailto:kay.diederi...@uni-konstanz.de>> wrote:

Proteopedia has this - see 
https://proteopedia.org/wiki/index.php/Proteopedia:Comments_on_Published_Structures

Kay

On Fri, 19 Jul 2019 17:42:33 +0000, Bonsor, Daniel 
<dbon...@som.umaryland.edu<mailto:dbon...@som.umaryland.edu>> wrote:

Would it be possible to add a public annotations section to the PDB, to allow 
us to potentially flag/warn whoever downloads that particular structure, there 
could be something wrong with it, such as wrong space group, no/poor density 
fitting for ligand. Something similar to PubPeer maybe?


Daniel A. Bonsor PhD
Institute of Human Virology,
University of Maryland at Baltimore
725 W. Lombard Street N571
Baltimore
MD 21201


________________________________
From: CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK<mailto:CCP4BB@JISCMAIL.AC.UK>> 
on behalf of Patrick Loll <pjl...@gmail.com<mailto:pjl...@gmail.com>>
Sent: Friday, July 19, 2019 1:17 PM
To: CCP4BB@JISCMAIL.AC.UK<mailto:CCP4BB@JISCMAIL.AC.UK> 
<CCP4BB@JISCMAIL.AC.UK<mailto:CCP4BB@JISCMAIL.AC.UK>>
Subject: Re: [ccp4bb] Questionable Ligand Density: 6MO0, 6MO1, 6MO2

The idea of contacting the editor (and/or author) is an excellent one, and 
indeed the correct thing to do scientifically. However, I�m disillusioned: I�ve 
been down this path before with a high-profile vanity journal, and while the 
editors paid lip service to the notion that the record should be corrected, in 
reality they led me on for the better part of a year, and got me to write up 
detailed analyses of why the ligand positioning was not justified, before 
eventually saying �no, we don�t see any need to publish a correction.� I 
speculate that the journal prefers not avoid corrections, for fear that too 
many corrections will make the journal a less desirable destination.

On 19 Jul 2019, at 11:23 AM, B�rbel Blaum 
<baerbel.bl...@intherabio.com<mailto:baerbel.bl...@intherabio.com>> wrote:

Hi Rhys,
the reported B-factors for the �ligands� are all way below the reported 
B-factors for the protein chains, with the worst of the three complexes 
reporting unitless numbers 23.2 and 64.8, respectively, just to highlight *one* 
striking feature of the data collection and refinement table. So even with the 
limited info normally available to reviewers this table should have raised a 
red flag. After the re-refinement suggested by others, i.e. your own proper 
assessment of the crystallographic data, if you do not find noteworthy density 
you may want to contact the article�s editor with your results. If you work in 
this field, i.e. really care about this paper scientifically and you are not 
afraid to confront the authors you could suggest writing a comment/direct 
response article but in my opinion that would only make sense if you can be 
sure beforehand that it will be linked visibly to the actual paper, else it 
will be a waste of time. And don�t forget that just because one or some of the 
authors did a bad job at the crystallographic end other findings of the paper 
might still be solid � in collaborations often one author is unable to 
critically evaluate another author�s contribution and this would not be the 
first case were good synthetic or biological work is presented along with a bad 
crystal structure.
By the way and a bit ironically this protein may have suffered bad 
crystallography/scientific practice before - I think it was one of the fake 
Krishna Murthy structures, right? The associated (now retracted) article I mean 
is here
https://www.sciencedirect.com/science/article/pii/S002228360093924X?via%3Dihub
[https://ars.els-cdn.com/content/image/S00222836.gif]<https://www.sciencedirect.com/science/article/pii/S002228360093924X?via%3Dihub>
RETRACTED: Crystal structure of dengue virus NS3 protease in complex with a 
bowman-birk inhibitor: implications for flaviviral polyprotein processing and 
drug design - ScienceDirect - ScienceDirect.com<http://ScienceDirect.com> | 
Science, health and medical journals, full text articles and 
books.<https://www.sciencedirect.com/science/article/pii/S002228360093924X?via%3Dihub>
www.sciencedirect.com<http://www.sciencedirect.com>
COMMUNIC Crystal Structure of Dengue Complex with a Bowman-Bir ro L. 1Center 
for Macromolecular C f A 8 U T MCLM 244, Birmingham AL 35294-0005, USA 
2Department of Biochemistry and Molecular Biology, Kansas University Medical 
Center 3901 Rainbow Boulevard Kansas City, KS 66160- 7421, USA Dengue viruses 
are members of the Flaviviridae and cause dengue fever Dengue fever and dengue 
hemorrhagic ...

Kind regards, B�rbel
---
B�rbel Blaum, PhD
Inthera Bioscience AG
Einsiedlerstrasse 34
CH-8820 Waedenswil
Switzerland
E-Mail: baerbel.bl...@intherabio.com
Phone: +41 43 477 94 72--



Von: CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK> im Auftrag von "Manfred S. 
Weiss" <manfred.we...@helmholtz-berlin.de>
Antworten an: "Manfred S. Weiss" <manfred.we...@helmholtz-berlin.de>
Datum: Freitag, 19. Juli 2019 um 16:03
An: <CCP4BB@JISCMAIL.AC.UK>
Betreff: Re: [ccp4bb] Questionable Ligand Density: 6MO0, 6MO1, 6MO2

Hi Rhys,

all three structures are at modest resolution and they don't seem to
be properly refined. At least they are all below average. I wonder
how this paper made it past the referees.

I haven't checked the paper, but there are ways and means how to
deal with weakly bound ligands in the best possible way. One aspect
is to improve the phases as much as possible without having the ligand
present. This was obviously NOT done. Another way is to use the
PANDDA approach, which relies on having many data sets available.
I suppose that this was also not done.

The best way to check is to delete the ligand and so some extensive
refinement in order to remove the phase bias introduced by the
ligand. Only then you can reliably assess whether something is there
or not.

Cheers, Manfred

Am 19.07.2019 um 15:21 schrieb Rhys Grinter:
Hi All,

I was chatting with a colleague during a recent synchrotron visit and they'd 
recently come across some ligand/drug bound structures associated with a paper 
recently published in a high impact factor journal.

They had pulled the associated SFs from the PDB and found that the electron 
density associated with these ligands didn't match that reported in the paper 
and certainly wasn't sufficient to model the alleged ligand.

I also pulled the structure factors and after refinement in the 
presence/absence of the alleged ligand I also feel that the density present 
does not warrant modelling of the ligand.

I was hoping that the community might be able to give me an outside opinion on 
these datasets (PDB IDs: 6MO0, 6MO1, 6MO2) and if the problem associated with 
the data is verified, provide some advice on how to proceed.

This isn't the first occasion I've seen ligand bound structures with 
questionable density deposited in association with papers in well respected 
journals. Despite improvements to validation I feel that this problem is 
widespread.

Best Regards,

Rhys

--
Dr Rhys Grinter
NHMRC Postdoctoral Researcher
Monash University
+61 (0)3 9902 9213
+61 (0)403 896 767

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1



--
Dr. Manfred S. Weiss
Macromolecular Crystallography
Helmholtz-Zentrum Berlin
Albert-Einstein-Str. 15
D-12489 Berlin
Germany


Helmholtz-Zentrum Berlin f�r Materialien und Energie GmbH

Mitglied der Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.

Aufsichtsrat: Vorsitzender Dr. Volkmar Dietz, stv. Vorsitzende Dr. Jutta 
Koch-Unterseher
Gesch�ftsf�hrung: Prof. Dr. Bernd Rech (Sprecher), Prof. Dr. Jan L�ning, Thomas 
Frederking

Sitz Berlin, AG Charlottenburg, 89 HRB 5583

Postadresse:
Hahn-Meitner-Platz 1
D-14109 Berlin

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


---------------------------------------------------------------------------------------
Patrick J. Loll, Ph. D.
Professor of Biochemistry & Molecular Biology
Drexel University College of Medicine
Room 10-102 New College Building
245 N. 15th St., Mailstop 497
Philadelphia, PA  19102-1192  USA

(215) 762-7706
pjl...@gmail.com
pj...@drexel.edu

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to